Liver carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
We suggest that the HFREP-1 gene is a new member of the fibrinogen family and that further data on the gene are important for a better understanding of the development of hepatocellular carcinomas.
|
8390249 |
1993 |
Hantavirus Infections
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Here, we describe characterization of the mouse Hps cDNA and genomic locus, and identification of pathologic Hps gene mutations in ep but not in ru mice, establishing mouse pale ear as an animal model for human HPS.
|
9158155 |
1997 |
Hantavirus Infections
|
0.100 |
GeneticVariation
|
group |
BEFREE |
A positional cloning strategy using yeast artificial chromosomes spanning the HPS locus was used to identify the HPS gene and its murine counterpart.
|
9256466 |
1997 |
Hermanski-Pudlak Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Organization and nucleotide sequence of the human Hermansky-Pudlak syndrome (HPS) gene.
|
9182823 |
1997 |
Hantavirus Infections
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Overall, however, we detected mutations in the HPS gene in only about half of non-Puerto Rican patients, and we present evidence that suggests locus heterogeneity for HPS.
|
9497254 |
1998 |
Hantavirus Infections
|
0.100 |
GeneticVariation
|
group |
BEFREE |
We have now identified a variant HPS cDNA that contains the same 5' sequence as the published HPS gene and a unique 3' sequence.
|
9579545 |
1998 |
Hermanski-Pudlak Syndrome
|
0.080 |
Biomarker
|
disease |
BEFREE |
Altered protein localization in melanocytes from Hermansky-Pudlak syndrome: support for the role of the HPS gene product in intracellular trafficking.
|
9759648 |
1998 |
Restrictive lung disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The 16-bp duplication in exon 15 of HPS, which we found only in Puerto Rican patients, is associated with a broad range of pigmentation and an increased risk of restrictive lung disease in adults.
|
9562579 |
1998 |
Hermanski-Pudlak Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Mutations in six genes have been reported to be responsible for different types of oculocutaneous and ocular albinism, including the tyrosinase gene (TYR) and OCA1 (MIM# 203100), the OCA2 gene and OCA2 (MIM# 203200), the tyrosinase-related protein-1 gene (TYRP1) and OCA3 (MIM# 203290), the HPS gene and Hermansky-Pudlak syndrome (MIM# 203300), the CHS gene (CHS1), and Chediak-Higashi syndrome (MIM# 214500), and the X-linked ocular albinism gene and OA1 (MIM#300500).
|
10094567 |
1999 |
Chediak-Higashi Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mutations in six genes have been reported to be responsible for different types of oculocutaneous and ocular albinism, including the tyrosinase gene (TYR) and OCA1 (MIM# 203100), the OCA2 gene and OCA2 (MIM# 203200), the tyrosinase-related protein-1 gene (TYRP1) and OCA3 (MIM# 203290), the HPS gene and Hermansky-Pudlak syndrome (MIM# 203300), the CHS gene (CHS1), and Chediak-Higashi syndrome (MIM# 214500), and the X-linked ocular albinism gene and OA1 (MIM#300500).
|
10094567 |
1999 |
Bartter Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
ABSTRACT.: Inherited hypokalemic renal tubulopathies are differentiated into at least three clinical subtypes: (1) the Gitelman variant of Bartter syndrome (GS); (2) hyperprostaglandin E syndrome, the antenatal variant of Bartter syndrome (HPS/aBS); and (3) the classic Bartter syndrome (cBS).
|
10906158 |
2000 |
Nephrocalcinosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hypocalciuria and hypomagnesemia are specific clinical features of Gitelman syndrome, while HPS/aBS is a life-threatening disorder of the newborn with polyhydramnios, premature delivery, hyposthenuria, and nephrocalcinosis.
|
10906158 |
2000 |
Bartter syndrome, type 3
|
0.010 |
Biomarker
|
disease |
BEFREE |
ABSTRACT.: Inherited hypokalemic renal tubulopathies are differentiated into at least three clinical subtypes: (1) the Gitelman variant of Bartter syndrome (GS); (2) hyperprostaglandin E syndrome, the antenatal variant of Bartter syndrome (HPS/aBS); and (3) the classic Bartter syndrome (cBS).
|
10906158 |
2000 |
CONSTRICTING BANDS, CONGENITAL
|
0.020 |
Biomarker
|
disease |
BEFREE |
We investigated 10 HPS/aBS patients for mutations in the ROMK gene by single-strand conformation polymorphism analysis (SSCA) and direct sequencing.
|
11318951 |
2001 |
Hermanski-Pudlak Syndrome
|
0.080 |
Biomarker
|
disease |
BEFREE |
Biogenesis of lysosome-related organelles complex 3 (BLOC-3): a complex containing the Hermansky-Pudlak syndrome (HPS) proteins HPS1 and HPS4.
|
12847290 |
2003 |
CONSTRICTING BANDS, CONGENITAL
|
0.020 |
Biomarker
|
disease |
BEFREE |
The evaluation of different disease-causing mechanisms will be essential for establishing new and more specific therapeutic strategies for HPS/aBS patients.
|
12911542 |
2003 |
Hantavirus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
Studies of the molecular functions of HPS proteins will reveal important details of vesicle trafficking and may lead to therapies for HPS.
|
15170859 |
2004 |
Liver carcinoma
|
0.050 |
Biomarker
|
disease |
BEFREE |
Loss of heterozygosity (LOH) analysis revealed allelic loss of LFIRE-1/HFREP-1 on chromosome 8p22 in 57.1% (24/42) of HCC specimens.
|
14981537 |
2004 |
Malignant Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
The reduction of LFIRE-1/HFREP-1 expression by antisense approach enhances cancer cell proliferation and colony formation in soft agar.
|
14981537 |
2004 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Furthermore, the reduction or nonexpression of LFIRE-1/HFREP-1 is significantly associated with the degree of tumor differentiation.
|
14981537 |
2004 |
Primary malignant neoplasm
|
0.020 |
AlteredExpression
|
group |
BEFREE |
The reduction of LFIRE-1/HFREP-1 expression by antisense approach enhances cancer cell proliferation and colony formation in soft agar.
|
14981537 |
2004 |
Hermanski-Pudlak Syndrome
|
0.080 |
Biomarker
|
disease |
BEFREE |
Hermansky-Pudlak Syndrome-type 3 (HPS-3) is a relatively mild subtype of HPS with minimal cutaneous and ocular depigmentation.
|
15632015 |
2005 |
Hypopigmentation disorder
|
0.020 |
Biomarker
|
disease |
BEFREE |
Hermansky-Pudlak Syndrome-type 3 (HPS-3) is a relatively mild subtype of HPS with minimal cutaneous and ocular depigmentation.
|
15632015 |
2005 |
Hantavirus Infections
|
0.100 |
Biomarker
|
group |
BEFREE |
All human HPS genes (HPS1-8) and five genes corresponding to murine HPS models were evaluated.
|
17041891 |
2006 |
Hantavirus Infections
|
0.100 |
GeneticVariation
|
group |
BEFREE |
This HPS database (HPSD; http://liweilab.genetics.ac.cn/HPSD/) provides integrated, annotatory, and curative data that is distributed in a variety of public databases or predicted by bioinformatics servers for the recently cloned human and mouse HPS genes, as well as for the genes responsible for HPSrelated syndromes, such as ChediakHigashi Syndrome (CHS), Griscelli syndrome (GS), oculocutaneous albinism (OCA), Usher syndrome type 1B (USH1B), and ocular albinism (OA).
|
16550546 |
2006 |